72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain.

72-year-old with intermediate (50-70%) stenosis in distal right coronary artery, who underwent coronary CTA due to atypical chest pain. (A) 3D volumetric rendering of coronary arteries, and (B) multiplanar reconstruction, show distal right coronary artery lesion (dashed box). (C) Image from onsite deep learning-based FFR-CT algorithm shows corresponding lesion (arrow). FFR-CT was 0.87. (D) Image from subsequent invasive coronary angiography shows corresponding lesion (arrow). Invasive FFR was 0.85, consistent with absence of hemodynamically significant stenosis. 


May 5, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), a high-speed onsite deep-learning based fractional flow reserve (FFR)-CT algorithm yielded excellent diagnostic performance for the presence of hemodynamically significant stenosis, with both high interobserver and intraobserver reproducibility. 

“A rapid and accurate onsite approach for determining FFR-CT should address challenges encountered in the clinical adoption of prior FFR-CT implementations,” wrote corresponding author Ronny Ralf Buechel, MD, from University Hospital Zurich in Switzerland. 


In this AJR accepted manuscript, 59 patients (46 men, 13 women; mean age 66.5 years) underwent coronary CTA (including calcium scoring) followed within 90 days by invasive angiography with invasive FFR and/or instantaneous wave-free ratio (iwFR) measurements from December 2014 to October 2021. Coronary artery lesions were considered to show hemodynamically significant stenosis in the presence of invasive FFR ≤0.80 and/or iwFR ≤0.89. A single cardiologist evaluated CTA images using an onsite deep-learning based semiautomated algorithm employing a 3D computational flow dynamics model to determine FFR-CT for coronary artery lesions detected by invasive angiography. Then, time for FFR-CT analysis was recorded. FFR-CT analysis was repeated by the same cardiologist in 26 randomly selected examinations, as well as by a different cardiologist in 45 randomly selected examinations.

Ultimately, Buechel et al.’s onsite deep-learning based FFR-CT algorithm evidenced AUC for hemodynamically significant stenosis—based on invasive angiography—of 0.975, sensitivity of 93.5%, and specificity of 97.7%. Among severely calcified lesions, their same algorithm had AUC of 0.991, sensitivity of 94.7%, and specificity of 95.0%. Moreover, the mean analysis time was 7 minutes and 54 seconds.   

“To our knowledge,” the authors of this AJR accepted manuscript added, “the currently reported mean processing timer represents the fastest reported time for onsite FFR-CT analysis.” 

For more information: www.arrs.org 


Find more ARRS23 conference coverage here 


Related Content

News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

June 9, 2026 — An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for ...

Time June 15, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Ultrasound Imaging

May 26, 2026 — A soft, wearable ultrasound patch that can continuously monitor a fetus for hours at a time — and it can ...

Time May 27, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
Subscribe Now